New Gut Microbiome Research Targets Portal Hypertension Dr David Johnson explores recent data with urolithin A, a gut metabolite that’s shown early promise in studies with portal hypertension.
Dr. David Johnson, MD works in Federal Way, WA as a Head & Neck Surgery Otolaryngologist and has 38 years experience. Dr. Johnson graduated from SOUTHWEST COLLEGE OF NATUROPATHIC MEDICINEHEALTH ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback